Federal Circuit: PTAB Erred In Presuming Nexus Where Commercial Product Was Not Coextensive With Patented Invention

Dec 27, 2019

Reading Time : 2 min

SRAM, LLC (“Patent Owner”) is the owner of Patent No. 9,182,027 (the ’027 Patent), which claims an improved bicycle chainring structure that maintains the bicycle chain in place better than existing chainrings. The claims at issue recite specific features, including alternating narrow and wide tooth tips and teeth offset from the center of the chainring. The claims do not, however, require additional chainring improvements identified in the specification, including an “80% gap-filling” feature. During IPR of a related patent, Patent Owner referred to this feature as “critical.”

Petitioner FOX Factory, Inc. filed two (simultaneous) IPR petitions requesting review of claims 1-26 of the ’027 Patent. Petitioner asserted a number of grounds alleging that the claims would have been obvious based on several prior art references. The PTAB instituted review on both petitions. In response, Patent Owner introduced evidence of a number of secondary considerations, relying on certain chainring products that allegedly embodied the invention. The PTAB found that a combination of prior art references disclosed every limitation of the independent claims at issue, and that a skilled artisan would have been motivated to combine those references. Nonetheless, in light of Patent Owner’s objective evidence, the PTAB determined that Petitioner failed to show that the challenged claims would have been obvious.

On appeal, the Federal Circuit found that the PTAB had applied the wrong standard to determine whether there was a presumption of nexus between the challenged claims and the objective evidence. Objective evidence is only given substantial weight if there is a nexus between that evidence and the challenged claims. When the objective evidence includes a product allegedly embodying a claim, a court presumes there is a nexus between the product and the claim if the product is “coextensive” with the claim. In this case, the PTAB interpreted the coextensiveness requirement to mean only that the claims must broadly cover the product. The Federal Circuit disagreed with that interpretation. The court explained that the mere presence of some unclaimed features in the product will not necessarily preclude a presumption of nexus—indeed, perfect correspondence between a product and a claim is rare. But a patent owner must show that the product is essentially the claimed invention. Here, the product in question included a number of unclaimed features that materially impacted the functionality of the product, and the Federal Circuit could not conclude that the product was the invention claimed in the ’027 Patent that would trigger a presumption of nexus. Accordingly, the burden to show sufficient nexus should have remained with Patent Owner. The Federal Circuit remanded for the PTAB to consider secondary consideration under the appropriate allocation of the burden.

Practice Tip: Patent owners relying on a product to show evidence of secondary considerations should assess whether the product embodies critical unclaimed features. If so, a patent owner would be well advised to include ample evidence of nexus when arguing nonobviousness, instead of simply relying on a presumption of nexus.

Fox Factory, Inc. v. SRAM, LLC, No. 2018-2024/2018-2025 (Fed. Cir. Dec. 18, 2019)

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.